RT Journal Article
SR Electronic
T1 Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004424
DO 10.1136/jitc-2021-004424
VO 10
IS 4
A1 Aggarwal, Charu
A1 Prawira, Amy
A1 Antonia, Scott
A1 Rahma, Osama
A1 Tolcher, Anthony
A1 Cohen, Roger B
A1 Lou, Yanyan
A1 Hauke, Ralph
A1 Vogelzang, Nicholas
A1 P Zandberg, Dan
A1 Kalebasty, Arash Rezazadeh
A1 Atkinson, Victoria
A1 Adjei, Alex A
A1 Seetharam, Mahesh
A1 Birnbaum, Ariel
A1 Weickhardt, Andrew
A1 Ganju, Vinod
A1 Joshua, Anthony M
A1 Cavallo, Rosetta
A1 Peng, Linda
A1 Zhang, Xiaoyu
A1 Kaul, Sanjeev
A1 Baughman, Jan
A1 Bonvini, Ezio
A1 Moore, Paul A
A1 Goldberg, Stacie M
A1 Arnaldez, Fernanda I
A1 Ferris, Robert L
A1 Lakhani, Nehal J
YR 2022
UL http://jitc.bmj.com/content/10/4/e004424.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.